Wnt signaling pathway and sclerostin in the development of atherosclerosis and vascular calcification

被引:3
作者
Kocelak, Piotr [1 ]
Puzianowska-Kuznicka, Monika [2 ,3 ]
Olszanecka-Glinianowicz, Magdalena [4 ]
Chudek, Jerzy [5 ]
机构
[1] Med Univ Silesia, Fac Med Sci, Dept Pathophysiol, Pathophysiol Unit, Katowice, Poland
[2] Med Ctr Postgrad Educ, Dept Geriatr & Gerontol, Warsaw, Poland
[3] Polish Acad Sci, Mossakowski Med Res Inst, Dept Human Epigenet, PL-02106 Warsaw, Poland
[4] Med Univ Silesiaia, Fac Med Sci Katowice, Dept Pathophysiol, Hlth Promot & Obes Management Unit, PL-40055 Katowice, Poland
[5] Med Univ Silesia, Fac Med Sci Katowice, Dept Internal Med & Oncol Chemotherapy, Katowice, Poland
来源
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE | 2024年 / 33卷 / 05期
关键词
atherosclerosis; aneurysm; cardiovascular disease; sclerostin; WNT-signaling; SMOOTH-MUSCLE-CELLS; BONE-MINERAL DENSITY; WNT/BETA-CATENIN; POSTMENOPAUSAL WOMEN; SERUM SCLEROSTIN; CIRCULATING SCLEROSTIN; AORTIC-ANEURYSM; KIDNEY-DISEASE; OSTEOBLAST DIFFERENTIATION; CONVERGENT EXTENSION;
D O I
10.17219/acem/169567
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Atherosclerosis is a complex process involving endothelial dysfunction, vascular inflammation, vascular smooth muscle cell (VSMC) proliferation, angiogenesis, and calcification. One of the pathomechanisms of atherosclerosis is the upregulation of Wnt signaling. This study aimed to summarize the current knowledge regarding the role of Wnt signaling and sclerostin in atherosclerosis, vascular calcification, aneurysms, and mortality based on the PubMed database. We followed the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) recommendation and identified 160 papers that were included in this systematic review. The published data highlight that the upregulation of Wnt components facilitates the initiation and progression of atherosclerosis, arterial remodeling, VSMCs proliferation and phenotypic transition to the osteoblastic lineage in the arterial wall. This results in protein secretion, cell migration, calcification, fibrosis and aneurysm formation. The transformation of VSMCs into osteoblast-like cells that is observed in atherosclerosis results in sclerostin expression inhibiting the Wnt pathway. Furthermore, it was shown that sclerostin, expressed in atherosclerotic plaques, inhibits aneurysm formation in a mouse model. However, in humans, while the antisclerostin antibody romosozumab inhibits bone resorption, biochemical parameters of endothelial activation and inflammation are not affected, and the incidence of aneurysms is not increased. It was suggested that detecting sclerostin in the calcified aortic atherosclerotic plaques reflects a defense mechanism against Wnt activation and inhibition of atherosclerosis, although this has only been shown in animal models. Moreover, an increased number of vascular cells converted to osteogenic phenotypes results in increased plasma sclerostin concentrations. Therefore, plasma sclerostin derived from bone limits its importance as a global marker of vascular calcification.
引用
收藏
页码:519 / 532
页数:14
相关论文
共 50 条
  • [21] The role of Wnt signaling pathway in atherosclerosis and its relationship with angiogenesis
    Du, Jingru
    Li, Junfeng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (03) : 1975 - 1981
  • [22] Wnt signaling in atherosclerosis
    Blankesteijn, W. Matthijs
    Hermans, Kevin C. M.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 763 : 122 - 130
  • [23] Wnt-β-catenin signaling pathway inhibition by sclerostin may protect against degradation in healthy but not osteoarthritic cartilage
    Wu, Jiang
    Ma, Long
    Wu, Long
    Jin, Qunhua
    MOLECULAR MEDICINE REPORTS, 2017, 15 (05) : 2423 - 2432
  • [24] Targeting the Wnt signaling pathway for the development of novel therapies for osteoporosis
    Yavropoulou, Maria P.
    Papapoulos, Socrates E.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (05) : 711 - 722
  • [25] Relationship between serum sclerostin, vascular sclerostin expression and vascular calcification assessed by different methods in ESRD patients eligible for renal transplantation: a cross-sectional study
    Li, Min
    Zhou, Hua
    Yang, Min
    Xing, Changying
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (02) : 311 - 323
  • [26] Osteoprotegerin, vascular calcification and atherosclerosis
    Van Campenhout, Ann
    Golledge, Jonathan
    ATHEROSCLEROSIS, 2009, 204 (02) : 321 - 329
  • [27] BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway
    Kamiya, Nobuhiro
    Ye, Ling
    Kobayashi, Tatsuya
    Mochida, Yoshiyuki
    Yamauchi, Mitsuo
    Kronenberg, Henry M.
    Feng, Jian Q.
    Mishina, Yuji
    DEVELOPMENT, 2008, 135 (22): : 3801 - 3811
  • [28] Inflammation: a culprit for vascular calcification in atherosclerosis and diabetes
    Bessueille, L.
    Magne, D.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2015, 72 (13) : 2475 - 2489
  • [29] Single-Pulsed Electromagnetic Field Therapy Increases Osteogenic Differentiation Through Wnt Signaling Pathway and Sclerostin Downregulation
    Lin, Chih-Chun
    Lin, Ru-Wei
    Chang, Chih-Wei
    Wang, Gwo-Jaw
    Lai, Kuo-An
    BIOELECTROMAGNETICS, 2015, 36 (07) : 494 - 505
  • [30] Sclerostin antibody promotes bone formation through the Wnt/β-catenin signaling pathway in femoral trochlear after patellar instability
    Xu, Chenyue
    Ji, Gang
    Chen, Xiaobo
    Yan, Lirong
    Liang, Tuwan
    Liu, Junle
    Wang, Fei
    CONNECTIVE TISSUE RESEARCH, 2023, 64 (02) : 148 - 160